Aktieanalys

Analyst Group's Comment on STENOCARE Launching Next Generation Medical Cannabis Oil Product in Australia

Analyst Group Publicerad: 23 May 16:11

STENOCARE announced on May 23rd that the company’s premium product, the Astrum oil, is ready for launch on the Australian market. The product is expected to have several benefits compared to the medical cannabis oil available today, including a higher, more uniform, and faster uptake in the blood. The first product, Astrum 10-10 oil Stenocare, with 10 mg/ml THC and 10 mg/ml CBD, are expected to be available for patients in Australia from the summer of 2024, six months ahead of schedule.

Länk till analysen i sin helhet: https://analystgroup.se/kommentarer/comment-on-stenocare-launching-next-generation-medical-cannabis-oil-product-in-australia/

Nyheter om Stenocare

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!